Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer.
about
Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecanMolecular therapeutics in pancreas cancerKey players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cellsAdjuvant therapy for pancreas cancer in an era of value based cancer careVaccines for pancreatic cancerPersistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinomaCD40 immunotherapy for pancreatic cancerInflammatory networks and immune surveillance of pancreatic carcinomaThe therapeutic value of targeting inflammation in gastrointestinal cancersRAS oncogenes: weaving a tumorigenic webInterleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistanceAdministration of cyclophosphamide changes the immune profile of tumor-bearing miceImmunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulationMast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma.Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study.Kras as a key oncogene and therapeutic target in pancreatic cancerA preclinical murine model of hepatic metastases.Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma.T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology.Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80(+) Extratumoral MacrophagesPancreatic ductal adenocarcinoma: a review of immunologic aspects.Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.IFNγ and CCL2 Cooperate to Redirect Tumor-Infiltrating Monocytes to Degrade Fibrosis and Enhance Chemotherapy Efficacy in Pancreatic CarcinomaMyeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancerInflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasiaTransformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model.Lack of immunoediting in murine pancreatic cancer reversed with neoantigen.High-fat, high-calorie diet promotes early pancreatic neoplasia in the conditional KrasG12D mouse model.Immune Suppression Mediated by Myeloid and Lymphoid Derived Immune Cells in the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by HrasG12V and Pten Loss.Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer.Potential targets for pancreatic cancer immunotherapeutics.Modulation of tumor tolerance in primary central nervous system malignancies.Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance.Immune infiltrates as predictive markers of survival in pancreatic cancer patients.Immunotherapy for lung cancer: for whom the bell tolls?CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer.Current management and future directions in metastatic pancreatic adenocarcinoma.Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunologic Markers.
P2860
Q26747695-3D1970CC-3ECF-472B-9BA2-1881161F12FCQ26751368-2F85E52D-1E62-44C7-8070-55736CC5AD53Q26751709-A9DA0E01-B7D5-49B9-8997-6AD8A3F71AF8Q26766065-63E45285-264E-4CE3-ADD5-C58573FCE128Q26775916-363DCE45-C18F-429E-B123-CE39E1C7BCA6Q26825850-48359394-9A77-42D7-AB74-1FE82AF1CE56Q27012236-2ACCED6D-7AA3-4FD1-A35E-3AAFA6EDE741Q27012550-06558BFA-95C3-4E1A-A425-AACFED2B6BFCQ27013983-93709A13-CF41-4168-A4DB-B543C0D73DBEQ27024203-6A58A672-3406-44B1-B053-39B543084EDFQ28250360-4782F823-FFF4-4FF9-8DD0-0BA9270316ADQ28504893-C2B2567A-C292-4EEB-9F2D-879B84910467Q33611809-B9EF2FA8-7BBF-4498-BE83-7FC59E0CC409Q33848077-E7235270-2E49-46F8-8297-BD5C9C6FCD70Q33872716-AD52208A-19DE-4FF1-9780-0DBCAFE3A5EDQ34566554-3760B04B-C7D1-4641-A1C9-9429685F8F0DQ34659332-002656D9-6CB6-450A-87AB-BF80B3CD823AQ35229297-8A21BA5A-BAF1-4738-A21D-2B85B2DCCBAEQ35329190-BC26A7AE-1F9D-4FFB-8789-7B178508F291Q35550879-2776FC49-22F4-4A79-A43F-84C11E993FDBQ35772377-03446D4D-53DB-4154-9BA1-7DFE73428D52Q35870682-AF1A1CF4-66A1-4915-89EC-E0B6F07D8F09Q36617328-A85811B1-C949-4FC4-99D3-CDBF630B2508Q36831774-88C0A788-0AF8-45B2-B21C-4E2D9AE8BB5AQ36896764-A9C39705-568F-4B80-A79B-6B0231B6AF2DQ36980064-8C919E0F-2901-4D4F-965A-3B5118B7BC4EQ37040899-D172763B-E332-462A-9E76-8D2A56579591Q37109800-C99A7534-0CB6-4723-9261-E19649F8FBD0Q37261700-B7230587-AC9A-4267-A6C6-52405FC5A556Q37328486-A723C98B-0EB1-4220-9E38-6BBA364147C8Q37486166-C9366D07-FAA1-4D05-BA99-572EDFDF2BD5Q37714611-D776CA40-6ACC-481D-9A64-1162F7B47B18Q37861220-209F8F14-A5CA-4DB4-AF17-0BAC7FBB6A4DQ37982065-3470324B-16CA-4665-BF2F-2EADEAB7DFD8Q38047057-F4FABDED-3796-409B-95DA-E51507BE3B50Q38129379-0FBAE98E-1ACC-4AD9-973B-3CF0CC93C554Q38367414-6A36A5F1-74A9-4C83-AED2-446C4BA9270EQ38711185-23F11D65-59FC-4865-A22D-4E87E86A5BF9Q38819470-9B0ECD17-5C67-4D97-8D74-1AA367FBFA02Q38872869-756BE282-2519-43AA-8F7C-23C3A7CE648B
P2860
Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Immunosurveillance of pancreat ...... neered mouse models of cancer.
@en
Immunosurveillance of pancreat ...... neered mouse models of cancer.
@nl
type
label
Immunosurveillance of pancreat ...... neered mouse models of cancer.
@en
Immunosurveillance of pancreat ...... neered mouse models of cancer.
@nl
prefLabel
Immunosurveillance of pancreat ...... neered mouse models of cancer.
@en
Immunosurveillance of pancreat ...... neered mouse models of cancer.
@nl
P1433
P1476
Immunosurveillance of pancreat ...... ineered mouse models of cancer
@en
P2093
Carolyn E Clark
Robert H Vonderheide
P356
10.1016/J.CANLET.2008.09.037
P407
P577
2008-11-14T00:00:00Z